Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

(Rac)-Naxifylline

Copy Product Info
🥰Excellent
Catalog No. T33600LCas No. 166181-76-6
Alias (Rac)-Naxifylline((Rac)-166374-49-8)

(Rac)-Naxifylline may be used to study congestive heart failure.

(Rac)-Naxifylline

(Rac)-Naxifylline

Copy Product Info
🥰Excellent
Purity: 99.39%
Catalog No. T33600LAlias (Rac)-Naxifylline((Rac)-166374-49-8)Cas No. 166181-76-6
(Rac)-Naxifylline may be used to study congestive heart failure.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$117In StockIn Stock
5 mg$290In StockIn Stock
10 mg$415In StockIn Stock
25 mg$648In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.39%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

(Rac)-Naxifylline AI Summary
(Rac)-Naxifylline exhibits a strong binding affinity for Adenosine A1 receptors across various mammalian species, with low Ki values ranging from 0.45 to 5.12 nM, indicating its potency. It also shows moderate binding to Adenosine A2 receptors, with Ki values ranging between 250.0 to 1250.0 nM, reflecting its selectivity towards A1 receptors. The compound has a significant selectivity index for human A1 over A2 receptors, represented by a fold change ratio of 400.0. In Saline-Loaded Rats, (Rac)-Naxifylline influences urine output and the excretion of sodium and potassium ions in a dose-dependent manner, suggesting its potential impact on renal function and electrolyte balance..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
(Rac)-Naxifylline may be used to study congestive heart failure.
Synonyms(Rac)-Naxifylline((Rac)-166374-49-8)
Chemical Properties
Molecular Weight344.41
FormulaC18H24N4O3
Cas No.166181-76-6
SmilesO=C1C=2NC(=NC2N(C(=O)N1CCC)CCC)C3CC4CC3C5OC54
Relative Density.no data available
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy (Rac)-Naxifylline | purchase (Rac)-Naxifylline | (Rac)-Naxifylline cost | order (Rac)-Naxifylline | (Rac)-Naxifylline chemical structure | (Rac)-Naxifylline formula | (Rac)-Naxifylline molecular weight